Liver transplantation in patients with alcohol-related liver disease: current status and future directions

2020 ◽  
Vol 5 (5) ◽  
pp. 507-514 ◽  
Author(s):  
Philippe Mathurin ◽  
Michael R Lucey
2017 ◽  
Vol 9 (1) ◽  
pp. 79-84 ◽  
Author(s):  
B Wang ◽  
K Agarwal ◽  
D Joshi

Chronic hepatitis B infection is a global public health problem associated with significant morbidity and mortality. Persistent infection may evolve to liver cirrhosis and hepatocellular carcinoma, and hepatitis B-related liver disease is a common indication for liver transplantation. Patients with advanced liver disease should be treated with antiviral therapy which may result in clinical improvement. The management of patients after liver transplant then focuses on preventing hepatitis B recurrence in the graft. With the introduction of prophylactic treatment, patient and graft survival has improved significantly. In this review, we will discuss the management of patients with hepatitis B-related cirrhosis, both compensated and decompensated. We also review the management of hepatitis B after liver transplantation.


Author(s):  
Thomas Marjot

This chapter covers core curriculum topics relating to liver disorders including the anatomy, physiology, and biochemistry of the liver as it relates to disease processes. There is a focus on the investigation and management of acute hepatitis including viral, drug- and toxin-induced, and the risk stratification of patients with acute liver failure. All major chronic liver diseases are discussed including non-alcoholic fatty liver disease, autoimmune liver disease, alcohol related liver disease and chronic viral hepatitis. There is also education on managing the complications of cirrhosis including renal dysfunction, hepatic encephalopathy, variceal haemorrhage, and spontaneous bacterial peritonitis. Additional important topics covered include nutrition in liver disease, hepatocellular carcinoma, liver transplantation indications and assessment, and complications following liver transplantation. Additional curriculum material regarding liver disorders will also be covered in the mock examination chapter.


2019 ◽  
Vol 56 ◽  
pp. 101227 ◽  
Author(s):  
Franck-Nicolas Bardou ◽  
Olivier Guillaud ◽  
Domitille Erard-Poinsot ◽  
Christine Chambon-Augoyard ◽  
Elsa Thimonier ◽  
...  

2020 ◽  
Vol 73 ◽  
pp. S279-S280
Author(s):  
Stephanie Turner ◽  
Ellie van der List ◽  
Kate Forgan-Smith ◽  
Maree Jarrett ◽  
Katherine Stuart

2018 ◽  
Vol 6 (2) ◽  
pp. 67-74
Author(s):  
Bharata Regmi ◽  
Manoj Kumar Shah

A liver transplantation (LT) is a surgical procedure that removes a liver that no longer functions properly and replaces it with a healthy liver from a living or deceased donor. It is a viable treatment option for end-stage liver disease and acute liver failure. The most commonly used technique is orthotopic transplantation or deceased donor liver transplantation (DDLT) in which the native liver is removed and replaced by the donor organ in the same anatomic location as the original liver. Ongoing challenges of LT include those concerning donor organ shortages, recipients with more advanced disease at transplant, growing need for transplantation, side effects associated with long-term immunosuppression, toxicities and obesity. Organ shortage has become the most vexing problem in LT, with 10–25% of patients dying while awaiting transplantation. Different ideas has been evolved like living donor liver transplantation (LDLT), marginal donor liver transplantation (MDLT) and  split liver transplantation (SLT) to overcome the growing problem of organ shortage. These techniques are becoming very important in an attempt to narrow the gap between demand and supply of organs. The advances in surgical and anaesthetic techniques, greater understanding of the physiological, haematological, biochemical, microbiological and immunological changes in liver disease and transplantation allowed a multidisciplinary approach that led to better outcomes. These changes, coupled with more effective immunosuppressive and anti-microbial agents and improvements in patient and donor selection, mean that now liver replacement is a routine procedure with excellent long term outcomes.Int. J. Appl. Sci. Biotechnol. Vol 6(2): 67-74 


1999 ◽  
Vol 67 (7) ◽  
pp. S198
Author(s):  
A Jain ◽  
A. DiMartini ◽  
N. Rishi ◽  
M G. Fitzgerald ◽  
S. Rohal ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document